Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 20, 2019
Event: Entry into a Material Definitive Agreement (First Modification to Loan and Security Agreement) with Tech Capital, LLC.
Key Financial Metrics
- Credit Facility Increase: Senior secured asset-based revolving credit facility increased from $1,000,000 to $2,500,000.
- Drawn Amount: Approximately $515,500 as of December 24, 2019.
- Minimum Monthly Interest Payment: Increased to $6,500.
- Loan Fee: 0.50% of the maximum available credit ($2,500,000), payable on the amendment date and each anniversary.
- Term: 12 months, with automatic renewal for successive 12-month periods.
- Collateral: Based on periodic borrowing base certifications of accounts receivable and inventory.
Material Changes Versus Prior Period
The primary material change is the expansion of the Company's borrowing capacity by $1,500,000. While the interest rate remains unchanged from the original August 17, 2017 agreement, the minimum monthly interest payment obligation has increased. The borrowing base calculations for accounts receivable and inventory were adjusted to support the higher credit limit.
Guidance, Outlook, and Risks
Use of Proceeds: The Company intends to use the proceeds for working capital and general corporate purposes.
Risks and Contingencies: The facility is asset-based, meaning availability is contingent upon the valuation of accounts receivable and inventory. The Company is subject to increased fixed costs regarding minimum interest payments and annual loan fees.
Investor Verification Checklist
- Verify the current valuation of accounts receivable and inventory to assess actual borrowing availability under the new $2,500,000 limit.
- Confirm the impact of the increased minimum monthly interest payment ($6,500) on the Company's cash flow projections.
- Review the full text of the First Modification to Loan and Security Agreement (Exhibit 10.1) for specific covenants and default provisions.
- Monitor the Company's ability to meet the 0.50% annual loan fee requirement.